Stefan Imobersteg Selected Research

glycyltryptophan

1/2020

Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [177Lu]Lu-PP-F11N.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Imobersteg Research Topics

Disease

3	Neoplasms (Cancer) 12/2021 - 01/2020
2	Stroke (Strokes) 01/2020 - 10/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Fatigue 10/2019
1	Cataplexy 12/2012

Drug/Important Bio-Agent (IBA)

3	minigastrinIBA 12/2021 - 01/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2021 - 01/2020
2	Everolimus FDA Link 12/2021 - 01/2020
2	Cholecystokinin B ReceptorIBA 11/2020 - 01/2020
2	Radioisotopes (Radionuclides)IBA 11/2020 - 01/2020
2	AntibodiesIBA 01/2020 - 10/2019
1	TOR Serine-Threonine KinasesIBA 12/2021
1	Actinium-225IBA 11/2020
1	PlasticsIBA 10/2020
1	alanyltyrosineIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 01/2020
1	aspartyl-phenylalanine (aspartylphenylalanine)IBA 01/2020
1	glycyltryptophanIBA 01/2020
1	LigandsIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 10/2019
1	almorexantIBA 12/2012
1	OrexinsIBA 12/2012

Therapy/Procedure

3	Therapeutics 11/2020 - 01/2020
1	Immunotherapy 10/2019